Table 5.
Key Summary Measures
| Proportion consenting | Proportion of offered population that consented to testing. | 
| Proportion ED population tested | Proportion of ED population tested. | 
| Proportion target population tested | Proportion of target population tested. | 
| Cost per patient tested | Estimated program costs divided by the number of tested patients. | 
| Proportion receiving confirmatory testing | Proportion of population preliminary positive that receives confirmatory testing. | 
| Proportion positive | Proportion of population tested that are confirmed to be positive. | 
| Positive predictive value of preliminary positive assay | Among patients for whom confirmatory test information is available, the proportion of preliminary positive test results that are confirmed to be positive. | 
| Proportion successfully notified | Proportion of population tested who are successfully notified of their results, categorized by test result. | 
| Proportion newly positive— or program prevalence | Proportion of population tested who are confirmed to be positive and not known to be previously diagnosed. | 
| Proportion linked positives | Proportion of newly positive population successfully linked to care. | 
| Confirmed positive CD4 count | Median value of CD4 counts obtained within 90 days of index test for population newly positive. | 
| Proportion late diagnoses | Proportion of population newly positive who have late diagnosis. | 
| Cost per positive | Estimated program costs divided by the number of newly positive persons. | 
| Cost per linked positive | Estimated program costs divided by the number of newly positive persons who were linked to care. | 
ED = emergency department.